Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $19.0300 (1.17%) ($18.8500 - $20.1000) on Thu. Mar. 31, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.18% (three month average) | RSI | 62 | Latest Price | $19.0300(1.17%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 2.7% a day on average for past five trading days. | Weekly Trend | ATRA advances 6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(58%) IBB(52%) ARKG(50%) IWO(48%) ARKK(45%) | Factors Impacting ATRA price | ATRA will decline at least -3.59% in a week (0% probabilities). VIXM(-17%) TLT(-13%) UUP(-10%) UNG(-3%) SHY(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.59% (StdDev 7.18%) | Hourly BBV | 0 () | Intraday Trend | -0.3% | | | |
|
5 Day Moving Average | $18.18(4.68%) | 10 Day Moving Average | $17.65(7.82%) | 20 Day Moving Average | $17.18(10.77%) | To recent high | -27.9% | To recent low | 35.8% | Market Cap | $1.414b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |